Tag: pharmaceuticals
-
What to Expect in Markets This Week: AMD, Palantir, Pharma and Tech Earnings, plus Private-Sector Hiring
Overview: A Week of High-Impact Earnings and Data This week’s market calendar centers on a battery of high-profile earnings reports from technology companies, alongside pivotal data on private-sector hiring. Investors will parse guidance and margins from semiconductor leaders, sift through software and AI spend trends from prominent analytics names, and assess the implications of the…
-
Vertex to Present at UBS Global Healthcare Conference on November 11, 2025
Vertex to Present at UBS Global Healthcare Conference on November 11, 2025 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that its leadership will participate in the UBS Global Healthcare Conference. Reshma Kewalramani, President and Chief Executive Officer, will participate in a fireside chat on Tuesday, November 11, 2025, at 10:15 a.m. ET. The discussion will…
-
Vertex to Participate in UBS Global Healthcare Conference with CEO Fireside Chat on November 11
Vertex Announces Participation in UBS Global Healthcare Conference Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that its leadership will participate in the UBS Global Healthcare Conference, underscoring the company’s ongoing efforts to advance treatments for serious diseases and its robust clinical program. Reshma Kewalramani, Ph.D., Chief Executive Officer and President, is slated to take part…
-
Commercial Applications of Chromatography in Industry
Introduction to Chromatography in Industry Chromatography is a foundational analytical technique used across many industries to separate the components of a mixture. By exploiting the different affinities of compounds for a mobile phase and a stationary phase, chemists can identify, quantify, and purify substances. Its commercial applications span food and beverage quality control, pharmaceutical development,…
-
Commercial Applications of Chromatography: From Labs to Industry
Introduction to Chromatography in Industry Chromatography is more than a laboratory technique; it is a workhorse of modern industry. By separating, identifying, and quantifying the components of complex mixtures, chromatography helps companies ensure product quality, safety, and compliance. The technique relies on differential affinities of compounds for a mobile phase and a stationary phase. The…
-
Commercial Applications of Chromatography: From Lab Bench to Industry
Introduction to chromatography and its industrial relevance Chromatography is a versatile analytical technique used to separate the components of a mixture based on their affinities for a mobile phase and a stationary phase. In commercial settings, chromatography underpins product quality, safety, and regulatory compliance. By enabling precise identification and quantification of substances—often at trace levels—chromatography…
-
Cough Syrup Scandal: MP Arrests Pharma Chief G Ranganathan as 21 Deaths Linked to Coldrif
Unfolding Allegations Eyed by Authorities The health and corporate worlds are rattled as Madhya Pradesh authorities arrest G Ranganathan, the 73-year-old owner of Sresan Pharmaceuticals based in Chennai, in connection with the toxic Coldrif cough syrup that has been linked to 21 deaths. A seven-member team from the state police and drug regulatory authorities carried…
-
Hong Kong Stocks Close Higher as Tech Index Surges on Oct 2
Market closes higher as tech stocks lead the rally Hong Kong’s equity market finished broadly higher on Tuesday, October 2, with the Hang Seng index gaining 1.61% to 27,287.12. The tech‑driven Hang Seng Tech Index surged 3.36% to 6,682.86, while the Mainland‑facing China Enterprises Index rose 1.77% to 9,724.38. The session reflected a broad appetite…
-
Trump 100% Tariffs on Drugs Shake Pharma Markets Today
Overview: Trump Announces 100% Tariffs on Drugs The White House has announced a sweeping 100% tariff on imported pharmaceuticals, to take effect starting October 1. The move is aimed at addressing what President Trump has described as an overwhelming influx of pharmaceutical products into the United States from abroad. In practice, the policy targets a…
-
Trump tariffs: Who stands to lose from new US pharma duties?
Trump’s latest tariff move arrives as a social-media surprise, with a 100% duty on branded or patented pharmaceutical products entering the United States unless manufacturers are building or planning to build US facilities. The post, made on Truth Social, did not include formal legislation, leaving industry and investors to parse what such a policy would…